======= CDK2AP2 ======= == Gene Information == * **Official Symbol**: CDK2AP2 * **Official Name**: cyclin dependent kinase 2 associated protein 2 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=10263|10263]] * **UniProt**: [[https://www.uniprot.org/uniprot/O75956|O75956]] * **Interactions**: [[https://thebiogrid.org/search.php?search=CDK2AP2&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20CDK2AP2|Open PubMed]] * **OMIM**: [[https://omim.org/entry/620061|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: Plays a role in regulating the self-renewal of embryonic stem cells (ESCs) and in maintaining cell survival during terminal differentiation of ESCs. Regulates microtubule organization of metaphase II oocytes (By similarity). Inhibits cell cycle G1/S phase transition by repressing CDK2 expression and activation; represses CDK2 activation by inhibiting its interaction with cyclin E and A (PubMed:23781148). {ECO:0000250|UniProtKB:Q9CPY4, ECO:0000269|PubMed:23781148}. |CDK2AP| |regulation of stem cell division| |negative regulation of G1/S transition of mitotic cell cycle| |negative regulation of cell cycle G1/S phase transition| |regulation of G1/S transition of mitotic cell cycle| |regulation of cell cycle G1/S phase transition| |regulation of cell division| |regulation of microtubule cytoskeleton organization| |negative regulation of mitotic cell cycle phase transition| |regulation of microtubule-based process| |negative regulation of cell cycle phase transition| |negative regulation of mitotic cell cycle| |microtubule| |negative regulation of cell cycle process| |regulation of mitotic cell cycle phase transition| |regulation of cell cycle phase transition| |regulation of cytoskeleton organization| |negative regulation of cell cycle| |regulation of mitotic cell cycle| |regulation of cell cycle process| |regulation of cell cycle| |regulation of organelle organization| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp7|Bortezomib 0.05μM R00 exp7]]|-1.82| ^Gene^Correlation^ |[[:human genes:h:hgc6.3|HGC6.3]]|0.404| Global Fraction of Cell Lines Where Essential: 1/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 3900 * **Expression level (log2 read counts)**: 4.64 {{:chemogenomics:nalm6 dist.png?nolink |}}